HSPA5 and chronic obstructive pulmonary disease: HSPA5 expression was also reduced by DE in cells treated with NTHi, compared to the air controls incubated with NTHi, with a significant reduction in both COPD and controls group (**p = 0.0014 and *p = 0.0230 respectively, Fig. 2b).